The Annual Sachs Biotech in Europe Forum is recognised as the leading international stage for those interested in investing and partnering in the biotech and life science industry and is highly transactional. The Forum draws together an exciting cross-section of early-stage/pre-IPO, late-stage and public companies with leading investors, analysts, money managers and pharma licensing executives.

Håkan Wickholm (CEO of Lytix Biopharma) will participate at the conference, 27^th-28^th September 2016 in Basel. He will both present the company and have meetings with relevant investors.